Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HERAN-Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC

NCT03742687 is registered in ClinicalTrials.gov with Danish Lung Cancer Group as lead sponsor.

NCT NCT03742687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03742687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HERAN-Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC
Lead sponsor
Danish Lung Cancer Group
Phase
Not applicable
Overall status
Recruiting
Start date
November 22, 2018
Completion date
December 30, 2026
Enrollment
151 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

radiotherapy side effect, stage iii non-small-cell lung cancer, stage iv non-small cell lung cancer